Skip to content

Effectiveness and Safety of Korean Medicine Treatment for Cervical Disc Herniation

Observational Study on Effectiveness and Safety of Integrative Korean Medicine Treatment for Cervical Disc Herniation With Radiculopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03959098
Enrollment
120
Registered
2019-05-22
Start date
2019-06-24
Completion date
2027-12-01
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain, Cervical Radiculopathy, Intervertebral Disc Displacement

Keywords

Korean Medicine, Effectiveness, Neck Pain

Brief summary

A prospective observational study investigating the effectiveness and safety of integrative Korean medicine treatment in cervical disc herniation patients with neck pain or cervical radiculopathy at 4 locations of Jaseng Hospital of Korean Medicine as assessed through of pain, functional disability, work loss and quality of life patient-reported outcomes

Detailed description

This is a prospective observational study to the aim of investigating the effectiveness and safety of integrative Korean medicine treatment (generally consisting of herbal medicine, Chuna manual medicine, bee venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, and cupping) in cervical disc herniation patients with neck pain or cervical radiculitis diagnosed by cervical MRI and clinical symptoms including cervical radiculopathy at 4 locations of Jaseng Hospital of Korean Medicine (Gangnam, Bucheon, Daejeon, Haeundae) as assessed through of pain, functional disability, work loss, and quality of life patient-reported outcomes with a 5-year follow-up period

Interventions

Herbal medicine will be administered in water-based decoction (120ml) and dried powder (2g) form (Ostericum koreanum,Eucommia ulmoides, canthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, aposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycinemax, Atractylodes japonica) at the physician's discretion.

Chuna is a Korean manual therapy directed at the spine and joints that incorporates various spinal manual medicine techniques for joint mobilization involving highvelocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manual medicine will be administered to the pelvic, lumbar, thoracic, and cervical vertebrae at the physician's discretion.

Bee venom pharmacopuncture will be administered only after confirming a negative response to hypersensitivity skin test. Diluted bee venom saline:bee venom ratio, 10,000:1) filtered for allergens will usually be injected at 4-5 acupoints proximal to the dysfunctional site at the physician's discretion. Each acupuncture point will be injected to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, hinchang medical co., Korea).

Pharmacopuncture consisting of select herbal ingredients will be dministered at Hyeopcheok (Huatuo Jiaji, EX B2), Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea) at the physician's discretion.

PROCEDUREAcupuncture

Acupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.

PROCEDUREElectroacupuncture

Electroacupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.

PROCEDURECupping

Cupping treatment will be administered at 1-2 points using mainly proximal acupuncture points and Ah-shi points.

Patients will be allowed any other additional intervention(s) as deemed necessary regardless of type or dose, and patterns of use will be investigated and recorded as a pragmatic clinical study.

Sponsors

Jaseng Medical Foundation
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients with age between 19 years \ 65 years * Patients with one arm pain or both side arm pain or neck pain with intensity of NRS ≥6 which occurred less then 12 month before * Patients with cervical radiculopathy symptoms of one or both side of arms * Patients diagnosed with cervical disc herniation with over protrusion degree of prolapsed inter-vertebral disc assessed on MRI * Patients with plans of receiving Korean medicine treatment for cervical disc herniation for ≥2 months * Patients who have agreed to study participation

Exclusion criteria

* Patients with other systemic diseases that may interfere with treatment effect or outcome interpretation * Patients with soft tissue pathologies or pathologies of non-spinal origin that may cause neck pain or radiating arm pain (e.g. spinal tumor, rheumatoid arthritis) * Patients with medical history of cervical myelopathy which can cause neck pain or radiating arm pain * Patients with medical history of surgery in relation with cervical disc herniation * Patients for whom acupuncture treatment may be inappropriate or unsafe (e.g. hemorrhagic diseases, blood clotting disorders, history of anticoagulation medicine intake, serious diabetes with risk of infection, severe cardiovascular diseases, or other conditions deemed unsuitable for acupuncture treatment) * Pregnant patients or patients planning pregnancy * Patients with serious psychological disorders * Patients unable to fill out study participation consent form * Patients deemed unsuitable for study participation as assessed by the researchers

Design outcomes

Primary

MeasureTime frameDescription
Change in Numeric rating scale (NRS) out of neck pain and radiating arm painTime Frame: Change from baseline to 4 monthsChange from higher score at baseline out of neck pain or radiating arm pain intensity to same score at 4 months. Total score range: -10 (worse outcome) to 10 (better outcome) Total score range: -10 (worse outcome) to 10 (better outcome)

Secondary

MeasureTime frameDescription
Visual analogue scale (VAS) of radiating arm painTime Frame: Baseline, 2, 4, 6, 8, 12, 16, 20, 24 weeks, 1, 3, 5 yearsRadiating arm pain intensity for the past 3 days. Total score range: 0 (better outcome) to 100 (worse outcome)
Neck Disability Index (NDI)Time Frame: Baseline, 2, 4, 6, 8, 12, 16, 20, 24 weeks, 1, 3, 5 yearsFunctional disability questionnaire. The possible range of each item score is 0 to 5. Total score range: 0 (better outcome) to 50 (worse outcome)
Patient Global Impression of Change (PGIC)Time Frame: 8, 16, 20, 24 weeks, 1, 3, 5 yearsGlobal patient-reported outcome. Total score range: 1 (better outcome) to 7 (worse outcome)
EuroQol 5-dimensions 5-levels (EQ-5D-5L)Time Frame: Baseline, 2, 4, 6, 8, 12, 16, 20, 24 weeks, 1, 3, 5 yearsHealth-related quality of life questionnaire. Total score range: 11111 (better outcome) to 55555 (worse outcome)
Type and frequency of other intervention(s)Baseline, 4, 8, 12, 16, 20, 24 weeks, 1, 3, 5 yearsUse of any other additional intervention(s) other than the integrative Korean medicine treatment administered by the attending physician (start date of treatment, end date of treatment, name of treatment, number of treatment sessions received, and other comments)
Visual analogue scale (VAS) of neck painTime Frame: Baseline, 2, 4, 6, 8, 12, 16, 20, 24 weeks, 1, 3, 5 yearsNeck pain intensity for the past 3 days. Total score range: 0 (better outcome) to 100 (worse outcome)
Type and frequency of adverse reaction(s)Baseline, 2, 4, 6, 8, 12, 16, 20, 24 weeks, 1, 3, 5 yearsSafety
Numeric rating scale (NRS) of Neck painBaseline, 2, 4, 6, 8, 12, 16, 20, 24 weeks, 1, 3, 5 yearsNeck pain intensity for the past 3 days. Total score range: 0 (better outcome) to 10 (worse outcome)
Numeric rating scale (NRS) of radiating arm painBaseline, 2, 4, 6, 8, 12, 16, 20, 24 weeks, 1, 3, 5 yearsRadiating arm pain intensity for the past 3 days. Total score range: 0 (better outcome) to 10 (worse outcome)
SF-36Baseline, 4, 8, 12, 16, 20, 24 weeks, 1, 3, 5 yearsThe Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
EQ-VAS[Time Frame: Baseline, 2, 4, 6, 8, 12, 16, 20, 24 weeks, 1, 3, 5 years]The EQ VAS records the respondent's self-rated health on a 20 cm vertical, visual analogue scale with endpoints labelled 'the best health you can imagine' and 'the worst health you can imagine'.
Physical examinationBaseline, 2, 4, 6, 8, 12, 16, 20, 24 weeks, 1, 3, 5 yearsCervical physical examination

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026